Literature DB >> 22706413

Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer's disease patients.

Manuela Padurariu1, Alin Ciobica, Ioannis Mavroudis, Dimitrios Fotiou, Stavros Baloyannis.   

Abstract

BACKGROUND: It is believed that in Alzheimer's disease (AD) some areas of the brain are particularly vulnerable to specific degenerative processes and that they could exhibit neuronal dysfunction in the earliest stage of the disease. The implications of the hippocampus in memory processes are very well known and it is likely that the hippocampus would be among the first areas of the brain affected by the pathogenic mechanisms occurring in AD. However, the distinction between the neurodegenerative changes that accompany normal ageing and those that characterize AD is not clear. Also, the distribution of the hippocampal cell loss in both normal aging and AD is not very well understood. SUBJECTS AND METHODS: In this context, we focused on the quantification of the neuronal density in the four specific areas of the hippocampus (CA1-CA4) of AD brains, as compared to an age-matched control group, by using the Nissl staining technique.
RESULTS: We found a significant reduction of neuronal density especially in the CA1 and CA3 hippocampal areas. The most prominent decrease was found at the CA1 area level, as compared to all other 3 areas which were analyzed.
CONCLUSIONS: In the present study we managed to demonstrate and confirm a significant neuronal loss of hippocampus in AD, as compared to an age-matched control group. Moreover, it seems that this decrease of hippocampal neuronal density is more prominent especially at the CA1 and also in the CA3 hippocampal areas. This could have important implications in the design of therapeutic and investigative strategies of AD. However, larger samples are necessary in order to provide the basis for firmer conclusions in this area of research.

Entities:  

Mesh:

Year:  2012        PMID: 22706413

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  63 in total

1.  β-Asarone Mitigates Amyloidosis and Downregulates RAGE in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Cong Yang; Xiaoguang Li; Yousheng Mo; Sijun Liu; Luguang Zhao; Xiaohui Ma; Zhigang Fang; Junli Chen; Yunbo Chen; Xuhua Yu; Shuhuan Fang; Yongbin Zhang; Shaoxiang Xian; Qi Wang
Journal:  Cell Mol Neurobiol       Date:  2015-08-14       Impact factor: 5.046

2.  Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.

Authors:  Olayemi Joseph Olajide; Nnaemeka Tobechukwu Asogwa; Blessing Oluwapelumi Moses; Christiana Bidemi Oyegbola
Journal:  Metab Brain Dis       Date:  2017-04-13       Impact factor: 3.584

3.  Rostral-Caudal Hippocampal Functional Convergence Is Reduced Across the Alzheimer's Disease Spectrum.

Authors:  Joseph Therriault; S Wang; S Mathotaarachchi; Tharick A Pascoal; M Parent; T Beaudry; M Shin; Benedet Al; M S Kang; K P Ng; C Dansereau; M T M Park; V Fonov; F Carbonell; E Zimmer; M Mallar Chakravarty; P Bellec; S Gauthier; P Rosa-Neto
Journal:  Mol Neurobiol       Date:  2019-06-22       Impact factor: 5.590

4.  Expression of Nampt in hippocampal and cortical excitatory neurons is critical for cognitive function.

Authors:  Liana Roberts Stein; David F Wozniak; Joshua T Dearborn; Shunsuke Kubota; Rajendra S Apte; Yukitoshi Izumi; Charles F Zorumski; Shin-ichiro Imai
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

5.  Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol.

Authors:  Liana G Apostolova; Chris Zarow; Kristina Biado; Sona Hurtz; Marina Boccardi; Johanne Somme; Hedieh Honarpisheh; Anna E Blanken; Jenny Brook; Spencer Tung; Darrick Lo; Denise Ng; Jeffry R Alger; Harry V Vinters; Martina Bocchetta; Henri Duvernoy; Clifford R Jack; Giovanni B Frisoni
Journal:  Alzheimers Dement       Date:  2015-01-22       Impact factor: 21.566

6.  Traffic-related air pollution impact on mouse brain accelerates myelin and neuritic aging changes with specificity for CA1 neurons.

Authors:  Nicholas C Woodward; Payam Pakbin; Arian Saffari; Farimah Shirmohammadi; Amin Haghani; Constantinos Sioutas; Mafalda Cacciottolo; Todd E Morgan; Caleb E Finch
Journal:  Neurobiol Aging       Date:  2017-01-13       Impact factor: 4.673

7.  Impact of hippocampal neuronal ablation on neurogenesis and cognition in the aged brain.

Authors:  S T Yeung; K Myczek; A P Kang; M A Chabrier; D Baglietto-Vargas; F M Laferla
Journal:  Neuroscience       Date:  2013-12-04       Impact factor: 3.590

8.  Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology.

Authors:  Stephanie L Adams; Kathy Tilton; James A Kozubek; Sudha Seshadri; Ivana Delalle
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-26       Impact factor: 3.685

9.  Lipopolysaccharide exposure in a rat sepsis model results in hippocampal amyloid-β plaque and phosphorylated tau deposition and corresponding behavioral deficits.

Authors:  Ryan A Kirk; Raymond P Kesner; Li-Ming Wang; Qi Wu; Rheal A Towner; John M Hoffman; Kathryn A Morton
Journal:  Geroscience       Date:  2019-08-31       Impact factor: 7.713

10.  Protective effect of chronic caffeine intake on gene expression of brain derived neurotrophic factor signaling and the immunoreactivity of glial fibrillary acidic protein and Ki-67 in Alzheimer's disease.

Authors:  Fatma M Ghoneim; Hanaa A Khalaf; Ayman Z Elsamanoudy; Salwa M Abo El-Khair; Ahmed M N Helaly; El-Hassanin M Mahmoud; Saad H Elshafey
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.